Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)

In article 1600202, CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to tumor cells with highly efficient anticancer and antimetastatic properties by Veronique Orian‐Rousseau, Pavel A. Levkin, and co‐workers. The modular synthesis and fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linxian, Schmitt, Mark, Matzke‐Ogi, Alexandra, Wadhwani, Parvesh, Orian‐Rousseau, Veronique, Levkin, Pavel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Cover Picture
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238733/
http://dx.doi.org/10.1002/advs.201770001
_version_ 1782495762717868032
author Li, Linxian
Schmitt, Mark
Matzke‐Ogi, Alexandra
Wadhwani, Parvesh
Orian‐Rousseau, Veronique
Levkin, Pavel A.
author_facet Li, Linxian
Schmitt, Mark
Matzke‐Ogi, Alexandra
Wadhwani, Parvesh
Orian‐Rousseau, Veronique
Levkin, Pavel A.
author_sort Li, Linxian
collection PubMed
description In article 1600202, CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to tumor cells with highly efficient anticancer and antimetastatic properties by Veronique Orian‐Rousseau, Pavel A. Levkin, and co‐workers. The modular synthesis and facile preparation makes this system highly potent for developing novel multifunctional nanocarriers for therapeutic and/or diagnostic anticancer applications. [Image: see text]
format Online
Article
Text
id pubmed-5238733
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52387332017-01-19 Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017) Li, Linxian Schmitt, Mark Matzke‐Ogi, Alexandra Wadhwani, Parvesh Orian‐Rousseau, Veronique Levkin, Pavel A. Adv Sci (Weinh) Cover Picture In article 1600202, CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to tumor cells with highly efficient anticancer and antimetastatic properties by Veronique Orian‐Rousseau, Pavel A. Levkin, and co‐workers. The modular synthesis and facile preparation makes this system highly potent for developing novel multifunctional nanocarriers for therapeutic and/or diagnostic anticancer applications. [Image: see text] John Wiley and Sons Inc. 2017-01-16 /pmc/articles/PMC5238733/ http://dx.doi.org/10.1002/advs.201770001 Text en © 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Cover Picture
Li, Linxian
Schmitt, Mark
Matzke‐Ogi, Alexandra
Wadhwani, Parvesh
Orian‐Rousseau, Veronique
Levkin, Pavel A.
Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
title Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
title_full Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
title_fullStr Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
title_full_unstemmed Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
title_short Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
title_sort cancer therapy: cd44v6‐peptide functionalized nanoparticles selectively bind to metastatic cancer cells (adv. sci. 1/2017)
topic Cover Picture
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238733/
http://dx.doi.org/10.1002/advs.201770001
work_keys_str_mv AT lilinxian cancertherapycd44v6peptidefunctionalizednanoparticlesselectivelybindtometastaticcancercellsadvsci12017
AT schmittmark cancertherapycd44v6peptidefunctionalizednanoparticlesselectivelybindtometastaticcancercellsadvsci12017
AT matzkeogialexandra cancertherapycd44v6peptidefunctionalizednanoparticlesselectivelybindtometastaticcancercellsadvsci12017
AT wadhwaniparvesh cancertherapycd44v6peptidefunctionalizednanoparticlesselectivelybindtometastaticcancercellsadvsci12017
AT orianrousseauveronique cancertherapycd44v6peptidefunctionalizednanoparticlesselectivelybindtometastaticcancercellsadvsci12017
AT levkinpavela cancertherapycd44v6peptidefunctionalizednanoparticlesselectivelybindtometastaticcancercellsadvsci12017

Ejemplares similares